TSOI — Therapeutic Solutions International Cashflow Statement
0.000.00%
- $0.01m
- $1.26m
- $0.10m
Annual cashflow statement for Therapeutic Solutions International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
| 2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Net Income/Starting Line | -1.7 | -2.2 | -2.96 | -3.88 | -2.22 | 
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.05 | 1.44 | 1.93 | 2.08 | 0.593 | 
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.33 | 0.088 | 0.299 | 0.518 | 0.265 | 
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.311 | -0.663 | -0.719 | -1.04 | -1.06 | 
| Capital Expenditures | — | -0.005 | -0.261 | 0 | -0.016 | 
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 0.004 | 0 | -0.008 | 
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.005 | -0.257 | 0 | -0.024 | 
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.315 | 0.894 | 0.817 | 0.943 | 1.08 | 
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.004 | 0.226 | -0.158 | -0.095 | -0.002 |